Inflammation predicts response to anti-depression medication
Children and teens with bipolar depression responded better to an antipsychotic medicine if they had increased markers of inflammation in their blood, a new University of Wisconsin–Madison study shows.
Biostatistics and medical informatics tapped for $11.8 million national coordinating center
A University of Wisconsin-Madison professor and his team have been chosen to lead the nation’s coordinating center for the National Cancer Institute (NCI) Cancer Prevention Clinical Trials Network (CP-CTNet).
Elizabeth Nugent named chief clinical research officer
Elizabeth “Betsy” Nugent, MSPH, CCRP, will become the inaugural Director of Clinical Trials Development and Accreditation/Chief Clinical Research Officer, effective September 3. Nugent is charged with leading the establishment of the School of Medicine and Public Health and UW Health as a premier clinical research organization.
Can a sleep device give deep-space explorers a good night’s rest?
The Wisconsin Institute for Sleep and Consciousness (WISC) will be one of two sites for testing a device that might improve sleep and thus waking performance for people on long space voyages.
UW program for advanced cell therapy launches first clinical trial
For the first time in Wisconsin, a research team will test a personalized cell therapy to treat a common and serious complication in bone-marrow transplant patients.
First Carbone Cancer Center patient receives experimental therapy to prevent infections during chemotherapy
Michael Toelle, superintendent of the Tomorrow River Schools, recently became the first patient at the University of Wisconsin Carbone Cancer Center to be infused with an experimental cellular therapy designed to prevent infections in leukemia patients.
Clinical prospects for stem cells begin to emerge
Twenty years after the University of Wisconsin–Madison’s James Thomson derived the first human embryonic stem cell lines (ESC), his revolutionary discovery is just beginning to emerge on the clinical landscape.
UW to test using MDMA in treatment of severe PTSD
The Department of Family Medicine and Community Health of the UW School of Medicine and Public Health will take part in a multisite Food and Drug Administration-approved Phase III trial investigating MDMA as an adjunct to psychotherapy for the treatment of severe post-traumatic stress disorder (PTSD).
Review of multiple studies shows early hormone use not associated with cognitive problems in healthy women
Hormone therapy is not associated with cognitive harm for women if therapy begins around the age of menopause in healthy women, according to University of Wisconsin-Madison research presented this week at the 2018 Alzheimer’s Association International Conference (AAIC) in Chicago.
UW–Madison and VA study veterans and Alzheimer’s disease
More than five million Americans are living with Alzheimer’s disease and experts expect that number to triple by 2050. And veterans face a higher risk than the general population.
Study identifies patients who benefit most from dinutuximab-based immunotherapy
Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the Children’s Oncology Group, researchers from the University of Wisconsin School of Medicine and Public Health found that a subset of patients, identified by the presence of a certain set of genes, were more likely to benefit from the immunotherapy than those patients that did not have that set of genes.
UW Carbone Cancer Center researchers win two national prostate cancer awards
UW Carbone Cancer Center researchers won two of the six national Challenge Awards announced this week by the Prostate Cancer Foundation and the Movember Foundation.